Worldwide Clinical Trials Recognized as Highest Rated Phase I Provider for Overall User Preference in 2024 Industry Standard Research Phase I Benchmarking Report [Yahoo! Finance]
Rhythm Pharmaceuticals, Inc. (RYTM)
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rhythmtx.com
Company Research
Source: Yahoo! Finance
RESEARCH TRIANGLE PARK, N.C., June 25, 2024 BUSINESS WIRE Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), proudly announces results of the 2024 Industry Standard Research (ISR) Phase I CRO Benchmarking Report. The findings confirm the importance of CRO partnerships and reinforce Worldwide's status as a top-performing CRO for Phase I services . View the full report here In an industry characterized by market consolidation, other recent surveys highlight increasing concerns among pharmaceutical and biotech firms regarding the stability of large CROs. This environment underscores the need for reliable CRO partners who can deliver foundational Phase I research with consistent high quality. The ISR report not only validates Worldwide's proven track record as a strong CRO partner but also underscores its steadfast dedication to operational excellence and leadership in an environment in which Phase I clinical trials are increasingly compl
Show less
Read more
Impact Snapshot
Event Time:
RYTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RYTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RYTM alerts
High impacting Rhythm Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RYTM
News
- Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 7.4% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $64.00 price target on the stock.MarketBeat
- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $64.00 price target on the stock.MarketBeat
- Rhythm Pharmaceuticals Announces New Employment Inducement GrantsGlobeNewswire
- Rhythm: Pivotal Moment Approaching In Hypothalamic Obesity (Rating Upgrade) [Seeking Alpha]Seeking Alpha
RYTM
Earnings
- 8/6/24 - Beat
RYTM
Sec Filings
- 9/19/24 - Form 8-K
- 9/19/24 - Form 4
- 9/17/24 - Form 144
- RYTM's page on the SEC website